STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3950 by analyst upside · 2026-08-13
PSNL
Personalis, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
-2.4%
implied upside to consensus target
Current Price $14.21
Consensus Target $13.88
Bull Target $16.25
Bear Target $10.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
2
Sell
0
52-Week Low $4.44
52-Week High $16.39
YTD Return +81.0%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.11
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $70M
Profit Margin -153.8%
52-WEEK RANGE
52-Week Low $4.44
52-Week High $16.39
Current Price $14.21
Bear Target $10.0
Bull Target $16.25
● Now $14.21 ● Target $13.88
TRADING DATA
Avg Volume 4.0M
YTD Return +81.0%
Analyst Count 4
Consensus Buy
Upside to Target -2.4%
Last Updated 2026-08-13

ANALYST SUMMARY

Personalis, Inc. (PSNL) is currently trading at $14.21 with a Wall Street consensus price target of $13.88, which is 2.4% below the current price over the next 12 months. 4 analysts currently cover PSNL, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $16.25, while the most cautious has a target of $10.0.

PSNL operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 81.0% year-to-date and is currently trading near the upper end of its 52-week range of $4.44 – $16.39.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PSNL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-05-12 Building track record
BTIG - Reiterated
Buy → Buy 2026-05-11 38% win rate (8 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-03-05 Building track record
Needham - Reiterated
Buy → Buy 2026-02-27 20% win rate (5 calls)
BTIG - Reiterated
Buy → Buy 2026-02-11 38% win rate (8 calls)
Guggenheim - Reiterated
Buy → Buy 2026-01-26 62% win rate (8 calls)
BTIG reit
Buy → Buy 2026-01-09 38% win rate (8 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2025-12-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
12/30
Consensus clarity
21/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →